Technology-enabled Management Versus Usual Care for Blood Pressure
Trial ID or NCT#
NCT05479461
Status
RECRUITING
Purpose
Two arm parallel randomized clinical trial
Official Title
A Two-arm Parallel Randomized Clinical Trial of Implementation of Technology-enabled Management Versus Usual Care for Blood Pressure
Eligibility Criteria
Ages Eligible for Study: 30 Years to 90 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
- * Age 30-90 yrs.* Smartphone ownership* Office SBP: ≥ 140 mm Hg* ≤ 2 current anti-HTN meds* Able to add or dose-increase at least 2 of the following classes of medications: ACE-I/ARB, diuretic, calcium channel blocker, beta-blocker, mineralocorticoid receptor antagonists (i.e., at least 2 classes are available for addition or dose- increases after excluding intolerant medications and medications currently at maximum dose)* English or Spanish-speakers
Exclusion Criteria:
- * Heart failure with reduced ejection fraction (EF \< 40%)* ESRD (GFR \<15)* Renal replacement therapy* Pregnant* Myocardial infarction or stroke within preceding 6 months* Hospitalization for hypertensive emergency or malignant hypertension within preceding 6 months* Prior solid organ transplantation* At the clinical discretion of the investigators* Enrolled in another clinical study
Investigator(s)
Paul J. Wang, MD
Cardiac electrophysiologist
John R. and Ai Giak L. Singleton Director, Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Bioengineering
Vishnu Ravi
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Contact us to find out if this trial is right for you.
Contact
Paul Wang, MD
650-723-9363
View on ClinicalTrials.gov
